­WAT Medical Reports Results of HeadaTerm TENS Therapy in a Clinical Study to Treat Acute Migraine

 ­WAT Medical Reports Results of HeadaTerm TENS Therapy in a Clinical Study to Treat Acute Migraine

¬WAT Medical Reports Results of HeadaTerm TENS Therapy in a Clinical Study to Treat Acute Migraine

Shots:

  • The clinical study involves assessing HeadaTerm TENS therapy in patients that were divided into two groups: a sham group & a verum group, both the groups underwent therapy for 20mins
  • The clinical study results: change in VAS from 0 to 120mins (-65.46 ± 25.11 & -9.46 ± 2.61); verbal score @120mins. (1.2 & 4.5); analgesic requirement after 120mins (76.92% & 2%); HeadaTerm TENS device demonstrated 11.8% better rate in decreasing pain than acute migraine medications
  • HeadaTerm is a wearable anti-migraine device that utilizes electrical stimulation to target CNS’pain receptors by releasing pain-countering neurotransmitters. HeadaTerm’s TENS therapy is the fast-acting and effective treatment of acute migraine

Click here ­to­ read full press release/ article | Ref: WAT Medical | Image: Wat Medical

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post